A detailed history of Cva Family Office, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cva Family Office, LLC holds 1,882 shares of NVO stock, worth $257,834. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,882
Previous 1,782 5.61%
Holding current value
$257,834
Previous $228,000 17.54%
% of portfolio
0.05%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$122.71 - $146.91 $12,271 - $14,691
100 Added 5.61%
1,882 $268,000
Q4 2023

Jan 16, 2024

BUY
$87.78 - $105.45 $156,423 - $187,911
1,782 New
1,782 $184,000
Q1 2022

Apr 22, 2022

SELL
$93.1 - $112.54 $38,171 - $46,141
-410 Reduced 33.17%
826 $92,000
Q4 2021

Jan 25, 2022

BUY
$95.88 - $117.08 $118,507 - $144,710
1,236 New
1,236 $138,000
Q3 2021

Oct 12, 2021

SELL
$84.42 - $106.62 $104,343 - $131,782
-1,236 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$67.66 - $84.76 $83,627 - $104,763
1,236 New
1,236 $104,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.